| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.16 | 0.3 |